查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2004990

即時檢測與快速診斷市場：2026-2032年全球市場預測（按產品類型、技術、檢測類型、最終用戶、應用和分銷管道分類）

Point of Care & Rapid Diagnostics Market by Product Type, Technology, Test Type, End User, Application, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，即時檢測和快速診斷市場價值將達到 556.1 億美元，到 2026 年將成長至 599.6 億美元，到 2032 年將達到 912.1 億美元，年複合成長率為 7.32%。

主要市場統計數據
基準年 2025 556.1億美元
預計年份：2026年 599.6億美元
預測年份 2032 912.1億美元
複合年成長率 (%) 7.32%

觀點清楚地反映了快速診斷正在分散檢測工作流程，並重新定義所有醫療保健機構中臨床決策的時間軸這一現實。

照護現場和快速診斷正在重塑臨床工作流程，使患者能夠更方便地獲得可操作的檢測結果，並加快臨床決策週期。試劑化學、小型化分析儀、高效能讀數器和資料管理軟體的進步，使得在門診中心、診所、居家照護機構和醫院等場所進行分散式檢查成為可能。隨著儀器操作日益便捷、連接性不斷提升，臨床醫生能夠更早介入並更有效地進行分診，從而改變患者的診療路徑和資源分配。

市場動態受技術融合、監管演變和醫療服務模式變革的影響。

目前情況是多種因素共同作用的結果，這些因素正在改變診斷檢測的地點和方式。分子診斷、免疫檢測和小型臨床化學平台的技術進步，使得在較小的面積內實現高分析性能成為可能。同時，數據管理軟體正從孤立的數據收集轉向整合解決方案，從而促進與電子健康記錄和遠端醫療平台的互通性。監管機構也在調整核准流程，以便更好地適應新的即時檢測技術。如果製造商能夠滿足品質和檢驗要求，則可以縮短臨床部署時間。

分析近期美國關稅措施對診斷生態系中的供應鏈、籌資策略和創新所產生的累積影響。

關稅政策的變化正在為全球診斷組件、試劑和成品儀器的供應鏈帶來明顯的摩擦。依賴跨境採購分析儀器、讀數器、試劑或關鍵電子元件的製造商正在調整其供應商組合和生產地點以降低風險。這種調整促使企業採取短期成本控制措施和策略採購策略，採購團隊專注於供應商多元化和合約柔軟性，以應對成本波動和物流延誤。

提供實用的細分見解，突顯跨產品類型、技術和最終用戶環境的需求推動要素和商業化重點。

從產品類型觀點來看，耗材、儀器和軟體/服務有不同的需求。對於耗材，例如試劑和檢測套組，批間一致性、穩定的保存期限和供應鏈的連續性至關重要。對於儀器，例如分析儀器和讀數器，穩健性、運轉率和易於維護是優先考慮的因素。另一方面，資料管理軟體和支援服務需要具備安全的互通性、分析能力和擴充性的服務合約。按技術領域分類，例如臨床化學、血液學、免疫檢測和分子診斷，可以突出檢驗流程和用戶期望的差異，其中分子診斷方法在病原體檢測和高靈敏度檢測方面特別引人注目。

在不同醫療保健系統和市場環境下實施即時護理解決方案的區域趨勢和實際考慮因素。

在美洲，集中式檢查室網路與門診和家庭環境中不斷擴展的即時檢測部署相結合，為與電子健康記錄整合並實現遠端監測的技術創造了機會。在歐洲和中東及非洲，由於報銷系統和基礎設施成熟度的差異，進展不相同。在某些市場，快速診斷正被納入國家篩檢和公共衛生舉措，而在其他市場，則更注重集中式檢查室的整合。在亞太地區，對分散式醫療路徑的投資、不斷增加的慢性病管理項目以及加速產品在地化的競爭性製造業基地，都在推動成長。

競爭格局分析，重點在於產品系列、服務提案和夥伴關係模式。

即時檢測和快速診斷領域的主要企業正透過整合模組化分析儀、耗材生態系統和雲端資料平台的整合解決方案來脫穎而出。產品系列將可靠的試劑、靈活的檢測套組以及注重運作的儀器相結合，為檢查室和醫院系統創造了極具吸引力的價值。同樣，投資於資料管理軟體和全面支援服務的機構，透過確保產品在整個生命週期內的連接性、合規性和可維護性，降低了部署門檻。

為行業領導者提供切實可行的、高優先級的建議，以加速採用新技術、保護利潤率並確保商業的未來。

製造商應優先考慮模組化設備架構，以便於組件更換和簡化維護，從而減輕供應鏈中斷對營運的影響。同時，投資於支援互通性和遠端診斷的資料管理軟體，將增強臨床醫生的信心，並支援基於服務的收入模式。從商業性角度來看，將定價和報銷策略與臨床結果和醫療保健總成本相結合，將有助於醫院網路和門診管道的推廣應用。

採用嚴謹的調查方法和資料整合方法，以產生可重複的見解並檢驗結論。

本研究整合了定性和定量證據，以深入了解市場動態。主要資訊來源包括對醫院、診斷檢查室、門診中心和居家照護機構的臨床決策者、採購經理和產品經理進行的結構化訪談。二級資訊來源包括同行評審文獻、監管指南和企業披露信息，以全面檢驗技術趨勢、檢驗要求和經營模式。

對於希望了解即時診斷趨勢的決策者而言，本書整合了策略見解並明確了優先事項。

快速診斷生態系統正處於技術進步、醫療服務模式演變和政策環境變化交匯的十字路口。決策者必須優先考慮硬體、耗材和軟體的整合，以確保在供應鏈和貿易趨勢變化的情況下，提供持續的臨床價值並維持營運韌性。同樣重要的是，要使商業化策略與終端使用者的工作流程、報銷實際情況以及當地醫療系統的特徵相契合。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 即時診斷與快速診斷市場：按產品類型分類

  • 消耗品
    • 試劑
    • 檢測套組
  • 裝置
    • 分析器
    • 領導者
  • 軟體服務
    • 資料管理軟體
    • 支援服務

第9章 即時診斷與快速診斷市場：按技術分類

  • 臨床化學
  • 血液學
  • 免疫檢測
  • 分子診斷

第10章 按檢測類型分類的即時檢測和快速診斷市場

  • 心臟標記物
  • 凝血
  • 血糖監測
  • 感染疾病
  • 懷孕與不孕

第11章 即時診斷與快速診斷市場：按最終用戶分類

  • 門診部
  • 診所
  • 檢查室
  • 居家照護設施
  • 醫院

第12章 即時診斷與快速診斷市場：按應用分類

  • 心臟護理
  • 血液凝固檢驗
  • 糖尿病管理
  • 感染疾病診斷
  • 腫瘤學
  • 妊娠測試

第13章 即時診斷與快速診斷市場：按分銷管道分類

  • 線上
  • 離線

第14章 即時檢測與快速診斷市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 即時診斷與快速診斷市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 即時診斷與快速診斷市場：按國家/地區分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國即時檢測與快速診斷市場

第18章：中國的即時偵測與快速診斷市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abaxis, Inc.
  • Abbott Laboratories
  • AccuBioTech Co., Ltd.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Boditech Med Inc.
  • Chembio Diagnostics, Inc.
  • Danaher Corporation
  • Eiken Chemical Co., Ltd.
  • ELITechGroup SAS
  • F. Hoffmann-La Roche Ltd.
  • Meridian Bioscience, Inc.
  • OraSure Technologies, Inc.
  • QuidelOrtho Corporation
  • Sekisui Diagnostics, LLC
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech plc
Product Code: MRR-742BD5183A2E

The Point of Care & Rapid Diagnostics Market was valued at USD 55.61 billion in 2025 and is projected to grow to USD 59.96 billion in 2026, with a CAGR of 7.32%, reaching USD 91.21 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 55.61 billion
Estimated Year [2026] USD 59.96 billion
Forecast Year [2032] USD 91.21 billion
CAGR (%) 7.32%

A clear-eyed orientation to how rapid diagnostics are decentralizing testing workflows and redefining clinical decision timelines across care settings

Point of care and rapid diagnostics are reshaping clinical workflows by delivering actionable results closer to patients and accelerating clinical decision cycles. Advances in reagent chemistry, miniaturized analyzers, robust readers, and data management software are enabling decentralized testing across ambulatory care centers, clinics, home care settings, and hospitals. As devices become easier to operate and connectivity improves, clinicians are better positioned to intervene earlier and to triage care more effectively, which in turn alters patient pathways and resource allocation.

Furthermore, as stakeholders increasingly prioritize value-based outcomes, diagnostics that deliver rapid, reliable, and actionable data are gaining practical priority. Laboratories and diagnostic networks are balancing central testing capacity with point of care capabilities to maintain quality while improving speed. Meanwhile, manufacturers are investing in integrated software and support services to ensure interoperability and to reduce total cost of ownership across installed bases. This intersection of technological progress, shifting care models, and rising expectations for timely results is creating a dynamic environment where clinical benefits, reimbursement pathways, and commercial execution must align for success

Transformative shifts in market dynamics driven by technological convergence, regulatory evolution, and changing care delivery models

The landscape is experiencing several converging drivers that are transforming where and how diagnostic testing occurs. Technological progress in molecular diagnostics, immunoassays, and compact clinical chemistry platforms is enabling higher analytical performance in smaller footprints. At the same time, data management software is moving from siloed data capture to integrated solutions that facilitate interoperability with electronic health records and telehealth platforms. Regulatory agencies are also adapting pathways to better accommodate novel point of care technologies, which reduces time to clinical adoption when manufacturers can meet quality and validation expectations.

Concurrently, the shift toward outpatient care and home-based monitoring is prompting manufacturers to re-evaluate form factors, ease of use, and channel strategies. Distribution channels that include direct sales, distributors, e-commerce platforms, and online retail are being optimized to reach new end users while maintaining post-market support through enhanced service models. As stakeholders adapt, market participants that invest in modular instrument architectures, scalable reagent systems, and cloud-enabled analytics will be better positioned to capture demand across cardiac care, diabetes management, infectious disease diagnostics, and oncology applications. In short, the next phase will reward cross-disciplinary integration that connects hardware, consumables, and software into user-centric solutions

Analysis of cumulative impacts from recent United States tariff actions on supply chains, procurement strategies, and innovation within the diagnostics ecosystem

Tariff policy shifts have introduced measurable friction into global supply chains for diagnostics components, reagents, and finished instruments. Manufacturers that rely on cross-border sourcing for analyzers, readers, reagents, or critical electronic components have adjusted supplier portfolios and production footprints to mitigate exposure. This rebalancing has driven near-term cost management activity and strategic sourcing efforts, with procurement teams focusing on supplier diversification and contractual flexibility to absorb cost volatility and logistical delays.

In addition, tariffs have influenced decisions about local assembly and regional manufacturing presence as companies evaluate the tradeoffs between incremental production costs and the benefits of supply resilience. For purchasers in hospitals, clinics, and diagnostic laboratories, procurement cycles are lengthening as stakeholders seek clarity around landed costs and service agreements. Meanwhile, suppliers are accelerating investments in automation and quality control to offset higher per-unit costs and to preserve margins without compromising product performance.

Looking forward, firms that proactively redesign sourcing strategies, prioritize modularity in instrument design to leverage interchangeable components, and strengthen strategic partnerships across distribution channels will reduce tariff-driven exposure. Equally important, regulatory and reimbursement stakeholders will need to consider the cumulative effect of these commercial responses on access and on the pace of innovation in high-impact areas such as molecular and immunoassay testing

Actionable segmentation insights that highlight demand drivers and commercialization priorities across product categories, technologies, and end-user settings

A product-type lens reveals distinct imperatives for consumables, instruments, and software & services. Consumables, including reagents and test kits, emphasize lot-to-lot consistency, shelf-life stability, and supply-chain continuity; instruments, spanning analyzers and readers, prioritize robustness, uptime, and ease of maintenance; while data management software and support services require secure interoperability, analytics capability, and scalable service contracts. Technology segmentation across clinical chemistry, hematology, immunoassay, and molecular diagnostics highlights divergent validation pathways and user expectations, with molecular approaches commanding particular attention for pathogen detection and high-sensitivity assays.

When examining test types such as cardiac markers, coagulation, glucose monitoring, infectious diseases, and pregnancy & fertility panels, commercialization strategies must align with clinical pathways and reimbursement realities to support clinician adoption. End-user segmentation emphasizes that ambulatory care centers and clinics prioritize rapid turnaround and portability, diagnostic laboratories focus on throughput and centralization, home care settings demand simplicity and remote data integration, and hospitals require integration into complex IT ecosystems. Application-focused strategies for cardiac care, coagulation testing, diabetes management, infectious disease diagnostics, oncology, and pregnancy testing must balance analytical rigor with user-centric design. Finally, distribution channel choices-direct sales, distributors, e-commerce platforms, and online retail-shape pricing, warranty models, and post-sale support, making channel strategy a core determinant of market reach and customer satisfaction

Regional dynamics and practical considerations for deploying point of care solutions across diverse healthcare systems and market environments

The Americas exhibit a heterogeneous mix of centralized laboratory networks and expanding point of care deployment in outpatient and home settings, which creates opportunities for technologies that integrate with electronic health records and enable remote monitoring. Across Europe, Middle East & Africa, differences in reimbursement structures and infrastructure maturity drive variable adoption curves; in some markets rapid diagnostics are being adopted as part of national screening and public health initiatives, whereas others emphasize centralized laboratory consolidation. In Asia-Pacific, growth is supported by investments in decentralized care pathways, rising chronic disease management programs, and a competitive manufacturing base that accelerates product localization.

Across all regions, regulatory alignment, reimbursement clarity, and supply chain resilience remain critical determinants of successful commercialization. Localized training and support models, tailored pricing strategies, and partnerships with clinical networks facilitate adoption. Moreover, interoperability with regional health information exchanges and telemedicine platforms enhances the clinical value proposition. Ultimately, companies that marry global best practices with local execution capabilities will unlock meaningful adoption across the Americas, Europe, Middle East & Africa, and Asia-Pacific

Competitive landscape insights focusing on product portfolios, service propositions, and partnership models that shape market positioning

Leading companies in the point of care and rapid diagnostics space are differentiating through integrated solutions that pair modular analyzers with consumable ecosystems and cloud-enabled data platforms. Product portfolios that combine reliable reagents and adaptable test kits with instruments engineered for uptime create compelling value for diagnostic laboratories and hospital systems. Equally, organizations that invest in data management software and comprehensive support services reduce adoption friction by ensuring connectivity, compliance, and lifecycle serviceability.

Partnership models are shifting toward co-development agreements with clinical institutions and technology providers to accelerate validation and to generate real-world evidence. Distribution strategies that blend direct sales with distributor partnerships and digital channels are enabling broader market reach while preserving local service capabilities. Competitive advantage increasingly depends on the ability to demonstrate outcomes, to reduce total cost of ownership, and to provide integrated post-sale support. Companies that align product development with clinician workflows and that leverage partnerships to deliver end-to-end solutions will maintain stronger positioning in a market where performance, service excellence, and interoperability determine buyer preference

Practical and prioritized recommendations for industry leaders to accelerate adoption, protect margins, and future-proof their operations

Manufacturers should prioritize modular instrument architectures that allow for component substitution and simplify servicing, thereby reducing the operational impact of supply chain disruptions. In parallel, investing in data management software that supports interoperability and remote diagnostics will enhance clinician trust and enable service-based revenue models. From a commercial perspective, aligning pricing and reimbursement strategies with clinical outcomes and total cost of care will facilitate adoption in both hospital networks and ambulatory channels.

Operationally, companies must strengthen multi-sourcing strategies, consider regional manufacturing partnerships to mitigate tariff exposure, and implement agile inventory management practices. Strategic collaborations with clinical sites for early validation and real-world evidence generation will accelerate payer engagement and clinician uptake. Finally, forging flexible distribution approaches that combine direct sales, careful distributor selection, and digital commerce will expand reach while preserving post-sale service standards. Taken together, these actions will help leaders maximize impact, sustain margins, and remain nimble in an environment characterized by rapid technological change and evolving care delivery models

Rigorous research methodology and data synthesis approach used to produce reproducible insights and validate conclusions

The research process integrated qualitative and quantitative evidence streams to create a robust understanding of market dynamics. Primary inputs included structured interviews with clinical decision-makers, procurement leaders, and product managers across hospitals, diagnostic laboratories, ambulatory care centers, and home care providers. Secondary sources encompassed peer-reviewed literature, regulatory guidance, and company disclosures to triangulate technology trends, validation requirements, and commercial models.

Data synthesis applied thematic analysis to capture common adoption barriers and enablement factors, while comparative case studies highlighted successful deployment models across different regions. Throughout, methodological safeguards ensured that conclusions relied on validated expert perspectives and documented performance characteristics rather than speculative forecasts. The approach prioritized transparency in assumptions and documented limitations to allow readers to interpret findings within the appropriate operational context. This methodological rigor produces actionable insights that are reproducible and applicable to strategy formulation, product development, and commercial planning

Concluding perspectives that synthesize strategic implications and reinforce priorities for decision-makers navigating the point of care diagnostics landscape

The rapid diagnostics ecosystem is at an inflection point where technological advances intersect with shifting care delivery models and evolving policy environments. Decision-makers must prioritize integration across hardware, consumables, and software to deliver consistent clinical value while maintaining operational resilience in the face of supply chain and trade dynamics. Equally important is the alignment of commercialization strategies with end-user workflows, reimbursement realities, and regional healthcare system characteristics.

Looking ahead, success will favor organizations that combine product excellence with robust service and data strategies, that invest in regional operational flexibility, and that cultivate partnerships to accelerate validation and adoption. By concentrating on modularity, interoperability, and outcomes-driven evidence generation, stakeholders can translate diagnostic innovations into measurable improvements in patient care. In sum, the pathway to sustainable growth rests on disciplined execution that bridges technical capability with pragmatic market implementation

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Point of Care & Rapid Diagnostics Market, by Product Type

  • 8.1. Consumables
    • 8.1.1. Reagents
    • 8.1.2. Test Kits
  • 8.2. Instruments
    • 8.2.1. Analyzers
    • 8.2.2. Readers
  • 8.3. Software & Services
    • 8.3.1. Data Management Software
    • 8.3.2. Support Services

9. Point of Care & Rapid Diagnostics Market, by Technology

  • 9.1. Clinical Chemistry
  • 9.2. Hematology
  • 9.3. Immunoassay
  • 9.4. Molecular Diagnostics

10. Point of Care & Rapid Diagnostics Market, by Test Type

  • 10.1. Cardiac Markers
  • 10.2. Coagulation
  • 10.3. Glucose Monitoring
  • 10.4. Infectious Diseases
  • 10.5. Pregnancy & Fertility

11. Point of Care & Rapid Diagnostics Market, by End User

  • 11.1. Ambulatory Care Centers
  • 11.2. Clinics
  • 11.3. Diagnostic Laboratories
  • 11.4. Home Care Settings
  • 11.5. Hospitals

12. Point of Care & Rapid Diagnostics Market, by Application

  • 12.1. Cardiac Care
  • 12.2. Coagulation Testing
  • 12.3. Diabetes Management
  • 12.4. Infectious Disease Diagnostics
  • 12.5. Oncology
  • 12.6. Pregnancy Testing

13. Point of Care & Rapid Diagnostics Market, by Distribution Channel

  • 13.1. Online
  • 13.2. Offline

14. Point of Care & Rapid Diagnostics Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Point of Care & Rapid Diagnostics Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Point of Care & Rapid Diagnostics Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Point of Care & Rapid Diagnostics Market

18. China Point of Care & Rapid Diagnostics Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abaxis, Inc.
  • 19.6. Abbott Laboratories
  • 19.7. AccuBioTech Co., Ltd.
  • 19.8. Becton, Dickinson and Company
  • 19.9. bioMerieux SA
  • 19.10. Boditech Med Inc.
  • 19.11. Chembio Diagnostics, Inc.
  • 19.12. Danaher Corporation
  • 19.13. Eiken Chemical Co., Ltd.
  • 19.14. ELITechGroup SAS
  • 19.15. F. Hoffmann-La Roche Ltd.
  • 19.16. Meridian Bioscience, Inc.
  • 19.17. OraSure Technologies, Inc.
  • 19.18. QuidelOrtho Corporation
  • 19.19. Sekisui Diagnostics, LLC
  • 19.20. Siemens Healthineers AG
  • 19.21. Sysmex Corporation
  • 19.22. Thermo Fisher Scientific Inc.
  • 19.23. Trinity Biotech plc

LIST OF FIGURES

  • FIGURE 1. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY READERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY READERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY READERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SUPPORT SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SUPPORT SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SUPPORT SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COAGULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COAGULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COAGULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY GLUCOSE MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY GLUCOSE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY GLUCOSE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COAGULATION TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COAGULATION TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COAGULATION TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PREGNANCY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PREGNANCY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PREGNANCY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 196. GCC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 197. GCC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. GCC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 199. GCC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 200. GCC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 201. GCC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 202. GCC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. GCC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. GCC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. GCC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 226. G7 POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 227. G7 POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. G7 POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 229. G7 POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 230. G7 POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 231. G7 POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 232. G7 POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. G7 POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. G7 POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. G7 POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 236. NATO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 237. NATO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. NATO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 239. NATO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 240. NATO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 241. NATO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 242. NATO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. NATO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 244. NATO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 245. NATO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 246. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 257. CHINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 263. CHINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 266. CHINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)